- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Squamous Cell Head and Neck Cancer
Total 15754 results
-
Krzysztof MisiukiewiczRegeneron PharmaceuticalsRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaUnited States
-
Hi-Q Marine Biotech International, Ltd.RecruitingSquamous Cell Carcinomas of the Head and NeckTaiwan
-
Guiyang Medical UniversityUnknownLocally Advanced Head and Neck Squamous Cell CarcinomaChina
-
Second Affiliated Hospital, School of Medicine,...RecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaChina
-
Indiana UniversityRecruitingSquamous Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Nonmelanoma Skin CancerUnited States
-
Tata Memorial HospitalActive, not recruitingOral Squamous Cell Carcinoma | Head and Neck Cancers | Carcinoma of Buccal Mucosa | Tongue CancersIndia
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingLung Cancer | Head and Neck Squamous Cell Carcinoma | Oesophageal CancerFrance
-
Hospital Universitario Doctor PesetRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaSpain
-
Abramson Cancer Center at Penn MedicineCompletedHead and Neck Squamous Cell CarcinomaUnited States
-
Arnaud Bewley, MDNational Cancer Institute (NCI); Genentech, Inc.TerminatedStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck | Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckUnited States
-
Maastricht University Medical CenterRecruitingQuality of Life | Satisfaction, Patient | Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of Head and Neck | Skin Cancer | Squamous Cell Carcinomas | Squamous Cell Carcinoma of the Skin | Cutaneous Squamous Cell Carcinoma of the Head and Neck | Cutaneous Squamous Cell Carcinoma | High-Risk CancerNetherlands
-
University of WashingtonNational Cancer Institute (NCI); AstraZenecaTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaUnited States
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
Emory UniversityNovartisCompletedHead and Neck Neoplasms | Cancer of the Head and NeckUnited States
-
University of Maryland, BaltimoreRecruitingHead and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Oropharynx Cancer | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Oropharynx Squamous Cell CarcinomaUnited States
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityRecruitingNeoadjuvant Therapy | Locally Advanced Head and Neck Squamous Cell CarcinomaChina
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Washington University School of MedicineMerck Sharp & Dohme LLC; Joseph Sanchez FoundationActive, not recruitingRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterWithdrawnRecurrent Head and Neck Squamous Cell Carcinoma | Unresectable Head and Neck Squamous Cell Carcinoma
-
National Cancer Centre, SingaporeInnogene Kalbiotech Pte. LtdCompletedHead and Neck CancerSingapore
-
Immunovative Therapies, Ltd.CompletedSquamous Cell Carcinoma of the Head and Neck | Cancer of Head and NeckThailand
-
Sesen Bio, Inc.TerminatedHead and Neck Cancer | Head and Neck Neoplasms | Carcinoma, Squamous Cell | Neoplasms, Squamous Cell | Mouth Neoplasms | Carcinoma, Squamous Cell of Head and NeckSpain, Germany, Israel, Italy, Poland, United Kingdom, India, Argentina, France, Hungary, Serbia, Croatia, Ukraine, Brazil, Russian Federation, Mexico, Romania, Slovakia
-
M.D. Anderson Cancer CenterOSI PharmaceuticalsWithdrawn
-
Merck Sharp & Dohme LLCCompletedHead and Neck Squamous Cell Carcinoma (HNSCC)United States, Australia, Austria, Brazil, France, Israel, Korea, Republic of, Norway, Spain, United Kingdom
-
Assistance Publique - Hôpitaux de ParisNational Cancer Institute (NCI); Canceropôle Ile de FranceCompletedHead and Neck Squamous Cell Carcinomas (HNSCCs)France
-
Rigshospitalet, DenmarkCompletedSquamous Cell Carcinoma of the Head and NeckDenmark
-
University of EdinburghRecruitingOropharyngeal Squamous Cell Carcinoma | Human Papillomavirus (HPV)United Kingdom
-
University of PittsburghNational Cancer Institute (NCI); University of ArizonaCompletedCarcinoma in Situ | Head and Neck Cancer | Hyperplasia | Head and Neck Carcinoma | Dysplasia | Head and Neck | Head and Neck Squamous Cell Carcinoma (HNSCC) | Tobacco-Related Carcinoma | Premalignant LesionUnited States
-
AVEO Pharmaceuticals, Inc.RecruitingRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head-and-neck Squamous-cell CarcinomaUnited States, Australia
-
M.D. Anderson Cancer CenterRecruitingRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaUnited States
-
University College, LondonMerck Sharp & Dohme LLCRecruitingRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaUnited Kingdom
-
Incyte Biosciences International SàrlWithdrawnRecurrent Head and Neck Squamous Cell Carcinoma | Advanced Malignancies | Metastatic Head and Neck Squamous Cell CarcinomaUnited States
-
Akamis BioBristol-Myers Squibb; Syneos HealthCompletedColorectal Cancer | Squamous Cell Carcinoma of the Head and Neck | Epithelial TumorUnited States
-
The First Affiliated Hospital of Soochow UniversityBiotech Pharmaceutical Co., Ltd.; Cinda Biopharmaceutical (Suzhou) Co., Ltd.Not yet recruitingRecurrent/Metastatic Head and Neck Squamous Cell Carcinoma
-
RTOG Foundation, Inc.Merck Sharp & Dohme LLCRecruitingHead and Neck Squamous Cell Carcinoma (HNSCC)Canada, United States
-
Washington University School of MedicineBristol-Myers SquibbActive, not recruitingMetastatic Head-and-neck Squamous-cell CarcinomaUnited States
-
University of NebraskaTerminatedDocetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckHead and Neck Squamous Cell CarcinomaUnited States
-
Sinocelltech Ltd.RecruitingHead and Neck Squamous CarcinomaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck | Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck | Stage...United States
-
Johns Hopkins UniversityCastle Biosciences IncorporatedRecruitingCutaneous Squamous Cell Carcinoma of the Head and NeckUnited States
-
Eisai Inc.PharmaBio Development Inc.CompletedPlatinum-Resistant Squamous Cell Carcinoma of the Head and NeckUnited States, Korea, Republic of, Ukraine, United Kingdom
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Emory University; University of... and other collaboratorsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN)United States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed
-
University of ArizonaNational Cancer Institute (NCI)CompletedCarcinoma in Situ | Head and Neck Cancer | Hyperplasia | Head and Neck Squamous Cell Carcinoma | HNSCC | Dysplasia | Tobacco-Related Carcinoma | Premalignant LesionUnited States
-
M.D. Anderson Cancer CenterNovartisCompletedHead and Neck Cancer | Squamous Cell CancerUnited States
-
Cue BiopharmaMerck Sharp & Dohme LLCActive, not recruitingHead and Neck Cancer | HPV-Related Carcinoma | HPV Positive Oropharyngeal Squamous Cell CarcinomaUnited States
-
China Medical University HospitalCompletedHead and Neck Squamous CarcinomaTaiwan
-
BioVex LimitedAmgenTerminatedHead and Neck Cancer | Squamous Cell CarcinomaUnited States, United Kingdom
-
Inge Marie SvaneWithdrawnHead and Neck Cancer | Squamous Cell CarcinomaDenmark